Luca Tottone, PhD, is a Senior Scientist in In Vivo Pharmacology at AstraZeneca, specializing in hematology oncology targeted discovery. They lead studies to evaluate the efficacy of various modalities such as small molecule inhibitors and PROTACs, particularly focusing on myelodysplastic syndromes and acute leukemias. With over 12 years of experience in target discovery and validation, Luca has authored eight scientific articles and holds an international patent for an anti-leukemic small molecule. They previously worked at the Sylvester Comprehensive Cancer Center, the Istituto Italiano di Tecnologia, and the Rutgers Cancer Institute of New Jersey. Luca earned a Bachelor’s degree in Biotechnology, a Master’s in Molecular Medicine, and a PhD in Molecular Medicine, all with honors, from institutions in Italy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices